SAN JOSE, Calif., March 25, 2024 (GLOBE NEWSWIRE) — Today, Zoom announced that Read more »
Zoom and Avaya announce new strategic partnership to deliver enhanced collaboration experiences
SAN JOSE, Calif. and MORRISTOWN, N.J., March 25, 2024 (GLOBE NEWSWIRE) — Today, Zoom and Avaya announced a strategic partnership designed to deliver enhanced collaboration experiences to global enterprises. As part of [...] Read more »
Zoom unveils AI-powered collaboration platform, Zoom Workplace, to reimagine teamwork
- Zoom Workplace, the new AI–powered collaboration platform, helps reimagine teamwork, facilitate connections, and improve productivity — all within the Zoom experience users [...] Read more »
Nyxoah Advances Patient Access Strategy through Partnership with the American Association of Otolaryngology – Head & Neck Surgery Foundation
Nyxoah Advances Patient Access Strategy through Partnership with the American Association of Otolaryngology – Head & Neck Surgery Foundation
First medical device company to become a [...] Read more »
Nyxoah Fait Progresser sa Stratégie d'Accès aux Patients en Annonçant un Partenariat Stratégique avec l'American Association of Otolaryngology – Head & Neck Surgery Foundation
Nyxoah Fait Progresser sa Stratégie d'Accès aux Patients en Annonçant un Partenariat Stratégique avec l'American Association of Otolaryngology – Head & Neck Surgery [...] Read more »
Cellebrite Files its 2023 Annual Report on Form 20-F
TYSONS CORNER, Va. and PETAH TIKVA, Israel, March 21, 2024 (GLOBE NEWSWIRE) — Cellebrite DI Ltd. (Nasdaq: CLBT), a leader in premier Digital Investigative solutions for the public and private sectors, today announced [...] Read more »
Zoom announces communications compliance solution, Zoom Compliance Manager
SAN JOSE, Calif., March 20, 2024 (GLOBE NEWSWIRE) — Read more »
Nyxoah Announces DREAM U.S. Pivotal Study Meets Primary Endpoints
Nyxoah Announces DREAM U.S. Pivotal Study Meets Primary Endpoints
Reports an Apnea–Hypopnea Index (AHI) responder rate of 63.5% on an intent to treat (ITT) basis [...] Read more »
Nyxoah Annonce que l'Étude Pivot DREAM U.S. Atteint les Critères d'Évaluation Primaires
Nyxoah Annonce que l'Étude Pivot DREAM U.S. Atteint les Critères d'Évaluation Primaires
Le taux de réponse à l'indice [...] Read more »
Zoom Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 2024
SAN JOSE, Calif., March 19, 2024 (GLOBE NEWSWIRE) — Zoom Video Communications, Inc. (NASDAQ: ZM), has been named to Fast Company’s prestigious list of the World’s Most Innovative Companies of [...] Read more »
Cellebrite Revolutionizes Data Collection with Ground-breaking SaaS Solution, Integral Part of Company’s Case-to-Closure Platform
TYSONS CORNER, Va. and PETAH TIKVA, Israel, March 14, 2024 (GLOBE NEWSWIRE) — Cellebrite DI Ltd. (Nasdaq: CLBT), a leader in Digital Investigative solutions, today unveils Cellebrite Endpoint Inspector SaaS. This [...] Read more »
Fortrea Assina Contrato Definitivo de Transferência das Unidades Endpoint Clinical e Patient Access para a Arsenal Capital Partners
A proposta da transferência das unidades Endpoint Clinical e Fortrea Patient Access agiliza ainda mais o foco estratégico da Fortrea como uma organização de pesquisa sob contrato
Read more »
Fortrea unterzeichnet endgültige Vereinbarung zur Veräußerung der Geschäftsbereiche Endpoint Clinical und Patient Access an Arsenal Capital Partners
Vorgeschlagene Veräußerung der Geschäftsbereiche Endpoint Clinical und Fortrea Patient Access optimiert Fortreas strategische Ausrichtung als reines Auftragsforschungsinstitut
Read more »
Fortrea signe un accord définitif pour céder les activités Endpoint Clinical et Patient Access à Arsenal Capital Partners
Le projet de cession des activités Endpoint Clinical et Fortrea Patient Access permet à Fortrea de se recentrer sur son cœur de métier stratégique d’organisme de [...] Read more »
Fortrea Signs Definitive Agreement to Divest Endpoint Clinical and Patient Access Businesses to Arsenal Capital Partners
Proposed divestiture of Endpoint Clinical and Fortrea Patient Access businesses further streamlines Fortrea’s strategic focus as a pure–play contract research organization
Read more »